Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Oct 08, 2020 10:15 AM - Oct 09, 2020 2:00 PM

(Eastern Standard Time)

Horsham, PA 19044

Master Protocol Workshop

Session 7: Global Regulatory Landscape/Perspectives

Session Chair(s)

Daniel  Millar, MBA

Daniel Millar, MBA

Senior Director, Strategic Business Transformation

Johnson & Johnson, United States

The unprecedented COVID-19 experience accelerated the call for Master Protocols from global regulators, as a means of generating timely and substantial evidence to help patients and to utilize research sites efficiently. This session will focus on how regulatory views are evolving and will address important challenges.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify similarities and differences in regulator experience, procedures, and opportunities for consultant
  • Evaluate how the regulatory environment for Master Protocols has changed since the COVID-19 experience
  • Identify specific points of attention to be successful with Master Protocol approaches to meet regulatory requirements


Gregory  Levin, PhD


Gregory Levin, PhD

FDA, United States

Associate Director for Statistical Science and Policy, OB, OTS, CDER

Dionne  Price, PhD


Dionne Price, PhD

FDA, United States

Deputy Director, Office of Biostatistics, OTS, CDER

Benjamin  Hofner, PhD

A European Regulator’s View on Master Protocols

Benjamin Hofner, PhD

Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Germany

Head of Data Science and Methods

Gustavo  Mendes Lima Santos, MPharm

Brazilian Experience with Master Protocols

Gustavo Mendes Lima Santos, MPharm

Brazilian Health Regulatory Agency (ANVISA), Brazil

Herbal and Complementary Medicines Office - GMESP

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.